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Introduction
Antimicrobial resistance (AMR) is a major public health concern globally and methicillin resistant Staphylococcus aureus (MRSA) is one of the most important pathogens worldwide [1, 2] . MRSA a prominent pathogen that causes severe infections from healthcare settings to various community settings over recent decades has raised considerable concern [1]. The resistance of S. aureus to methicillin is mainly mediated by the gene mecA, which is located on Staphylococcus cassette chromosome mec (SCCmec), a mobile genetic element that encloses a modified penicillin-binding protein with reduced affinity to β-lactam antibiotics, which contributes to inactivating antibiotics [3] .
MRSA in hospital settings is more prevalent in Asian countries such as South Korea, China, and Japan, with reported rates of 70-80% and Europe (25.1%) [4, 5] . In one recent study, the proportion of MRSA in Health care-associated (HA) isolates was very high, 73.3% [6] . Although rates of Community-associated (CA) MRSA infections are still very low in South Korea, recent rates of MRSA isolates have been unclear [7, 8] .
Resistance to antimicrobial agents has become one of the most serious problems worldwide, especially resistance to nosocomial pathogens.
Excessive therapeutic usage of antimicrobial agents in both humans and animals has contributed to the development of widespread antibiotic resistance in bacteria [9] , and multidrugresistant S. aureus is causing public health problems that should arouse societies attention [10] .
MRSA can lead to difficult-to-treat infections because they are resistant to many groups of antibiotics such as β-lactams, tetracyclines, aminoglycosides, and macrolides. The principal mechanism of aminoglycoside resistance in S. aureus is drug inactivation mediated by aminoglycoside-modifying enzymes (AMEs) encoded by various genes such as aac(6')-aph(2") and ant(4 ' )-Ia [11] . The most prevalent AME in S. aureus is bifunctional enzyme AAC(6 ' )-APH (2 " ) , which is encoded by aac(6')-aph (2") [12] . In addition, ANT(4')-I encoded by ant(4')-Ia, erm(A), erm(C) and tetM has been found in S. aureus [13] [14] [15] .
MRSA is resistant to all penicillins including semisynthetic penicillinase-resistant congeners, carbapenems, cephalosporins, and penems [16] . The principal mechanism of penicillin resistance in MRSA is mediated by mecA, which encodes a modified penicillin-binding protein with reduced affinity to βlactam antibiotics [17, 18] . Another mechanism of penicillin resistance is the expression of penicillinase, which hydrolyzes the β-lactam ring, which in turn inactivates penicillin [18] . The resistance of S. aureus to methicillin is caused by the presence of the mecA gene, which encodes the 78-kDa penicillin-binding protein (pbp) 2a (or pbp2a). Than b-lactam antibiotics cannot bind to pbp2a, synthesis of the peptidoglycan layer and cell wall synthesis are able to continue [19, 20] .
S. aureus can acquire antibiotic resistance genes through horizontal gene transfer using mobile genetic elements include SCCmec, plasmid, transposon, insertion sequence, and bacteriophage [21] . SCCmec elements are important for MRSA because they usually serve as determinants of antibiotic resistance patterns. Health care-associated MRSA strains usually harbor type I-III SCCmec elements that confer Multidrug Resistance (MDR) [22] .
However, community-associated strains are generally non-MDR strains that carry small SCCmec elements; most of these elements are types IV and V [23, 24] . There have, however, been recent reports from clinical trials of the efficacy of beta-lactams and carbapenems in S. aureus [25] [26] [27] .
Our objectives with this study were to compare the relationship between phenotypic antimicrobial susceptibility patterns and pbp genes were present in bacteria isolated strains. Also to compare the prevalence of genes with SCCmec resistance with blaTEM and pbp genes among clinical S. aureus isolate strains.
Materials and Methods

Bacterial isolates
A total of 134 S. aureus strains were obtained from clinical patients at Gachon University Gil Medical Center in South Korea between April 2016 and June 2018. The research was approved by the ethics committee of Gil Hospital, Gachon University of Medicine. S. aureus strains identification and antimicrobial susceptibility testing of S. aureus isolated from blood culture were performed using MicroScan Pos Breakpoint Combo panel type 28 (PBC28; Beckman Coulter, West Sacramento, CA, USA).
Sample strains were streaked onto sheep blood agar (Sinyang Diagnostics, Seoul, Korea) and transported to our laboratory after culture. One colony was picked from each blood agar plate and incubated in lysogeny broth with shaking (80 rpm) at 37°C overnight. Isolates were preserved in 20% glycerol (vol/vol) and stored at -80°C freezer until further use.
Antimicrobial susceptibility testing
We tested for antimicrobial susceptibility using the Kirby-Bauer disc diffusion method described by Clinical and Laboratory Standard Institute (CLSI) guidelines; 2015 [28] . Each bacterial suspension was adjusted to McFarland 0.5 turbidity, swabbed onto lysogeny broth agar, and incubated in the presence of antibiotic discs at 37°C for 18 hours. We tested the following 19 antibiotic discs (Liofilchem, Roseto degli Aburzzi, Italy): penicillin G (10 IU), methicillin (5 μg), kanamycin (30 μg), gentamicin (10 μg), streptomycin (10 μg), tetracycline (30 μg), erythromycin (15 μg), vancomycin (30 μg), chloramphenicol (30 μg), amoxicillin (25 μg), ticarcillin (75 μg), piperacillin (100 μg), cefepime (30 μg), cefotaxime (30 μg), ceftazidime (30 μg), imipenem (10 μg), ertapenem (10 μg) and meropenem (10 μg).
We measured the diameters of inhibition zones ≤ 10-13 mm and determined each isolate as resistant or susceptible to antimicrobial agents based on CLSI 2015 and Liofilchem (Liofilchem, Roseto degli Aburzzi, Italy) guidelines. We obtained S. aureus control strain Staphylococcus aureus ATCC 29213 (Korean Culture Center of Microorganisms, Seodaemun-gu, Seoul, Korea).
Genomic DNA isolation
Genomic DNA was isolated after alkaline cell lysis, phenolchloroform DNA extraction, and ethanol DNA precipitation. A single colony was picked from each blood agar plate and then incubated in lysogeny broth at 37°C overnight. Then 1.5 ml of the bacterial suspension was harvested by centrifugation at 14,000 rpm for 30 s.
The harvested bacterial pellet was proceeded protocol alkaline phenol chloroform method. We were used fresh tube and phenol-chloroform (1:1) solution (Bioneer, Daejeon, Korea). DNA pellet was then dissolved in 30 μl autoclaved tri-distilled water. DNA concentrations were determined using a NanoDrop TM spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA).
Identifying mecA, blaTEM and SCCmec typing by multiplex real time-PCR
We have used to detect mecA and blaTEM gene list in Table 1 [12, 15, 29, 30] . The following reaction mixture was added to each sample: 10 pmol of each primer, 2 μl DNA (100 ng), and 10 μl iQ TM SYBR ® Green supermix (2×reaction buffer with dNTPs, iTaq DNA polymerase, SYBR ® Green I, fluorescein, and stabilizers, Bio-Rad, Hercules, CA, USA). The volume was adjusted to 20 μl by adding autoclaved triple-distilled water. PCR cycling conditions on a thermal cycler (iQ5, Bio-Rad and TC-512, TECHNE, Cambridge, UK) were as follows: 94°C for 3 min followed by 35 cycles of denaturation at 94°C for 30 s, annealing at 56°C for 30 s, and extension at 72°C for 45 s.
The reaction was ended with a final extension step at 72°C for 10 min. Multiplex PCR was carried out for SCCmec typing using nine pairs of primers specific for SCCmec types I, II, III, IVa, IVA, IVb, IVc, IVd, and V primer sets by Zhang et al. [30] . PCR products were subjected to electrophoresis using 2% agarose gel in 1×TBE buffer at 100 V for 25 min. The 100 bp DNA ladder (Bioneer, Daejeon, Korea) was used as a molecular size maker. PCR products in gels were then visualized with Safe Green loading dye (Applied Biological Materials Inc, Vancouver, Canada). 
Detecting genes associated with carbapenem related genes and pbp genes
We performed PCR to detect genes associated with antimicrobial resistance; oligonucleotide primer sequences and specific genes are listed in Table 2 . These products were determined the existence of carbapenem related genes and pbp genes PCR result and DNA sequencing. 
Results
We tested for antimicrobial susceptibility using Kirby-Bauer disc diffusion and determined the isolates as resistant or susceptible to antimicrobial agents based on the diameters of the inhibition zones ≤ 10-13 mm. Our susceptibility testing showed that 58.96% (79/134) of S. aureus strains were resistant to methicillin; our results showed high rates of susceptibility to chloramphenicol 132/134 (98.51%) and vancomycin 132/134 (98.51%), but S. aureus strains showed resistance against streptomycin 128/134 (95.52%) and penicillin 111/134 (82.84%). The overall rates of resistance to kanamycin, gentamicin, erythromycin, and tetracycline were 55.97%, 45.52%, 34.34%, and 24.63% ( Table 3) .
Our susceptibility testing also showed that 81/134 (60.45%) of S. aureus strains were susceptible to amoxicillin (AML), and we found resistance against piperacillin 42/134 (31.34%) and cefotamxime 27/134 (20.15%) as well. Table 3 displays the results for correlations between methicillin resistance and the presence of mecA gene. A total of 79 MRSA strains resistant to methicillin, 77 strains were mecA positive and 2 strains were mecA negative (Table 3, Figure 1a ). Fifty-seven (42.54%) strains of S. aureus were susceptible to methicillin. The relationship between penicillin resistance and the presence of blaTEM is also summarized in Table 3 . One hundred-eleven (82.84%) S. aureus strains were resistant to penicillin based on disk diffusion, and 107 of them were positive for blaTEM (Table 3, Figure 1a ). Tables 3 shows the correlations between kanamycin resistance and the presence of ant(4')-Ia and aac(6')-aph(2") in S. aureus; a total of 68/134 (50.75%) strains carried at least one of the genes. Seventy-five S. aureus strains were resistant to kanamycin, including 48 that carried resistance genes, and 16 strains were positive for ant(4')-Ia and aac(6')-aph(2") by PCR. Sixty-one (45.52%) S. aureus strains were resistant to gentamycin as determined by disk diffusion, and 36 of these were positive for aac(6')-aph (2") (Table 3, Figures 1b-1d) .
The correlations between erythromycin resistance and the presence of ermA and ermC are summarized in Table 3 . A total of 46 (34.34%) S. aureus were resistant to erythromycin determined by disc diffusion, including 38 that were positive for ermA and two that had carried ermC ( Table 3) ; however, 88/134 (65.67%) susceptible strains did not harbor either of these two genes associated with erythromycin resistance based on multiplex PCR. There were correlations between tetracycline resistance and the presence of tetM ( Table 3) : Thirty-three (24.63%) S. aureus strains were resistant to tetracycline on the susceptibility test, but 45 were positive for tetM by PCR ( Table  3 ). We used multiplex PCR to determine SCCmec types in 77 mecA-positive strains (Figure 1a) . The prevalence of different SCCmec types in mecA-positive MRSA strains is summarized; the predominant type was SCCmec type II 32/77 (41.56%). The prevalence rates of type IVA and non-typable were 40.26% (31/77) and 18.18% (14/77) by multiplex PCR.
The correlations between carbapenem resistances and the presence of SCCmec types are shown in Table 4 . A total of 32/77 (41.56%) SCCmec type II strains were resistant to piperacillin 21/32, cefotaxime 22/32, and imipenem 22/32, and 31/77 (40.26%) SCCmec type IVA strains were resistant to piperacillin 11/31, cefotaxime 9/31, and imipenem 5/31. Fourteen 14/77 (18.18%) non-typable strains were resistant to ticarcillin 5/14, cefepime 5/14, and meropenem 3/14; SCCmec type II had higher carbapenem resistance than did type IVA and nontapable strains ( Table 4) . We have analysed relationship between carbapenems related resistance phenotypes and pbp1,2,3,4 genes expression in total 134 S. aureus (Table 5 ). *Abbreviation: TMall is all positive; TM4 is TEM; penicillin; mecA and methicillin positive; TP is TEM and penicillin positive; AM is penicillin; mecA and methicillin positive; TEM is only positive; Penic is Penicillin positive; ETC is rest strains
Discussion and Conclusion
In the present study, we compared the results of antimicrobial susceptibility determined by disc diffusion with PCR analysis results for S. aureus strains ( Table 3) . Although results of the present study showed almost perfect correlation between phenotypic methicillin susceptibility and mecA, two strains presented discrepancies between genotype and phenotype, as did two methicillin-resistant mecA-negative strains. Previous researchers have reported that S. aureus isolates that carry mecA are sensitive to oxacillin, and thus, mecA might be heterogeneously expressed; therefore, some S. aureus strains that carry mecA might not be detectable with phenotypical methods [12, 31] . The possibility of selecting resistant cells from originally susceptible strains has been demonstrated; some strains do not express their mecA unless they are provided with selective pressure via increasing gradients of the antibiotic agent. The second case of discrepancy occurred in two mecAnegative S. aureus strains that were phenotypically resistant to methicillin and mecA gene was not detected in these isolates. We will proceed investigation with further study in these two isolates (continue to study, approximate type mecC). Researchers have reported that penicillin resistance in S. aureus is commonly mediated by the expression of penicillinase encoded by blaZ and hydrolyze the β-lactam ring and contribute to the inactivation of penicillin [9, 16, 32, 33] .
However, others have investigated the presence of blaTEM were unclear. It is known that blaTEM encodes a series of class A plasmid-mediated enzymes belonging to extended-spectrum βlactamases that are associated with penicillin resistance and are frequently present in Klebsiella pneumoniae and Escherichia coli [34, 35] . In addition, three strains that showed penicillin resistance were blaTEM-negative and pbp3 gene negative; thus, penicillin resistance in these strains might not be associated with mecA but other resistance genes. We result of pbp3 and pbp4 have been considered not so important for mecA and TEM resistance in S. aureus sample strains.
In harbored ant(4')-Ia were resistant to kanamycin, and all strains that carried aac(6')-aph (2") were clearly resistant to gentamicin and kanamycin in susceptibility testing [11] . Our results were phenotypically resistant to kanamycin, including three that showed kanamycin resistance in susceptibility testing but did not carry ant(4')-Ia or aac(6')-aph (2") . The prevalence of phenotypic tetracycline resistance and carried tetM were discrepances. These discrepancies also suggested that some strains might harbor tetracycline resistance genes and variable measured the diameters of inhibition zones ≤ 13 mm.
We evaluated the prevalence of different types of SCCmec by multiplex PCR. Commonly, HA-MRSA strains carry SCCmec types I-III with multidrug resistance while CA-MRSA strains harbor types IV and V. Previous researchers in South Korea have indicated that SCCmec type II is the most prevalent among HA-MRSA strains while SCCmec type IVA is predominant in CA-MRSA strains, but other researcher were different higher prevalence types IV [8, 36] .
Multiplex PCR results revealed that the predominant SCCmec type among 77 mecA-positive MRSA strains were similer too SCCmec type II (32/77) and type IVA (31/77). The predominant SCCmec type II had more carbapenem resistances than IVA, IVb and IVd. TEM and mecA gene expression were not correlated with pbp gene, and the properties of drug resistance were appeared not associated with pbp3, 4 genes.
The strains of SCCmec type II had higher carbapenem resistance than did type IVA ( Table 4 ). Excessive therapeutic usage of antimicrobial agents in hospital environments might have contributed to the development of resistance and the widespread distribution of SCCmec type II MRSA strains. Recent clinical trials ongoing demonstrate the efficacy of beta-lactams and carbapenems in S. aureus [25] [26] [27] . However, this efficacy remains to be tested in future studies using phenotypegenotype pairs for the diagnostic microbiology and monitor resistance trends in infection control. 
